For 2021, 71 percent of surveyed investment professionals expect that biopharmaceutical companies will target early stage, highly innovative assets. This statistic illustrates the percentage of expected acquisitions by biopharmaceutical companies in 2021, by type of asset.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
KPMG. (March 27, 2021). Expected targets of biopharmaceutical acquisitions in 2021, by asset type [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 26, 2026, from /statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
KPMG. "Expected targets of biopharmaceutical acquisitions in 2021, by asset type." Chart. March 27, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 26, 2026. /statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
KPMG. (2021). Expected targets of biopharmaceutical acquisitions in 2021, by asset type. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 26, 2026. /statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
KPMG. "Expected Targets of Biopharmaceutical Acquisitions in 2021, by Asset Type." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 27 Mar 2021, /statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
KPMG, Expected targets of biopharmaceutical acquisitions in 2021, by asset type ÌÇÐÄÆƽâ°æ, /statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/ (last visited July 26, 2026)
Expected targets of biopharmaceutical acquisitions in 2021, by asset type [Graph], KPMG, March 27, 2021. [Online]. Available: /statistics/1240055/expected-acquisitions-by-biopharma-industry-by-asset/
